Axsome Therapeutics, Inc. (AXSM) — Analyst estimates
Consensus analyst estimates for Axsome Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 311.52M | 0.38 | 3 |
| 2027 | 458.76M | 1.71 | 2 |
| 2028 | 698.43M | 4.53 | 5 |
| 2029 | 3.11B | 25.48 | 14 |
| 2030 | 3.79B | 32.53 | 14 |
Consensus analyst estimates by fiscal year.